| Date Filed | Type | Description |
| 07/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2018 |
4
| Talbot George Harrison (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Bought 14,500 shares
@ $2.75, valued at
$39.9k
|
|
| 05/04/2018 |
4
| Talbot George Harrison (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Granted 29,000 options
@ $0 |
|
| 09/29/2017 |
4
| Talbot George Harrison (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Exercised 1,350 options
@ $0 |
|
| 09/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2017 |
4
| Talbot George Harrison (Director) has filed a Form 4 on Nabriva Therapeutics Plc|
Txns:
| Acquired 31,790 shares
@ $0
Acquired 40,000 options
@ $0
Acquired 10,100 options
@ $0 |
|
| 06/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/01/2017 |
4
| Talbot George Harrison (Director) has filed a Form 4 on Nabriva Therapeutics AG|
Txns:
| Sold 110 shares
@ $101.5, valued at
$11.2k
Sold 100 shares
@ $101, valued at
$10.1k
|
|
| 05/25/2017 |
4
| Talbot George Harrison (Director) has filed a Form 4 on Nabriva Therapeutics AG|
Txns:
| Sold 30 shares
@ $99.7, valued at
$3k
Sold 205 shares
@ $100.5, valued at
$20.6k
Sold 90 shares
@ $101, valued at
$9.1k
|
|
| 05/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/30/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |